Baxter Bros Inc’s iShares Biotechnology ETF IBB Stock Holding History

Baxter Bros Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$644K	Buy	3,812 +1,200	+46%	+$205K	0.08%	107
2025 Q4	$441K	Buy	2,612 +240	+10%	+$39K	0.05%	121
2025 Q3	$342K	Buy	+2,372	New	+$324K	0.04%	128
2025 Q2	–	Sell	-1,989	Closed	-$254K	–	155
2025 Q1	$254K	Buy	1,989 +373	+23%	+$50.6K	0.03%	138
2024 Q4	$214K	Sell	1,616 -756	-32%	-$106K	0.03%	152
2024 Q3	$345K	Sell	2,372 -552	-19%	-$79.9K	0.04%	127
2024 Q2	$401K	Sell	2,924 -681	-19%	-$90.9K	0.05%	119
2024 Q1	$495K	Buy	3,605 +593	+20%	+$81K	0.06%	108
2023 Q4	$409K	Buy	3,012 +1,183	+65%	+$144K	0.06%	113
2023 Q3	$224K	Buy	+1,829	New	+$233K	0.03%	137

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baxter Bros Inc's IBB Position: Q1 2026 in Review

Baxter Bros Inc increased its iShares Biotechnology ETF (IBB) stake by 46% in Q1 2026, buying an estimated $205K and bringing the position to 3,812 shares worth $644K. The position accounts for 0.08% of the portfolio, ranked #107.

Baxter Bros Inc first reported a position in IBB in Q3 2023 and has held it in 10 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Baxter Bros Inc held 3,812 shares of iShares Biotechnology ETF worth $644K as of Q1 2026.
Baxter Bros Inc bought 1,200 iShares Biotechnology ETF shares in Q1 2026, an estimated $205K.
iShares Biotechnology ETF made up 0.08% of Baxter Bros Inc's portfolio in Q1 2026, its #107 holding.
Baxter Bros Inc first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 10 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.